SUIG News & Events

SUI Group announced that as of May 19, 2026, its total SUI holdings increased to 108,793,779, primarily driven by lending activities in the SUI ecosystem and native staking rewards. The Company also noted that the discount of its share price to net asset value has compressed meaningfully in recent months reflecting new investments, the appreciation in the SUI price and adjustments in the book value of the legacy lending book. Based on current market prices, SUI Group is trading at an approximate 0.91x market net asset value, which management believes reflects increasing investor recognition of its differentiated treasury strategy and long-term positioning within the Sui ecosystem. SUI Group's total shareholders' equity, as set out in the company's most recent 10Q filing, was $100,788,670 as of March 31, 2026. SUI Value: Approximately $115M using the May 19, 2026 price of $1.06 per SUI.

SUI Group Holdings co-led with Karatage Opportunities a $15 million funding round for Nof1, a world-class AI research lab training frontier models focused on financial markets, SUI Group has also made a strategic investment in Recursive Superintelligence's recent $650 million funding round, an AI research company building self-improving AI systems, valued at more than $4 billion. Sui Group invested $3 million in each of Nof1 and Recursive Superintelligence. Both investments were made alongside Karatage, the London-based proprietary hedge fund specializing in digital assets and emerging technology. SUI Group and Karatage made their strategic investments directly into Nof1 and, separately, into Recursive Superintelligence via a structured deal with Twin Path ventures. Karatage owns 5.63% of the common stock of SUI Group and acts as strategic advisor to the Company. Marius Barnett and Stephen Mackintosh, who are co-founders of Karatage Opportunities, serve as SUI Group's Chairman of the Board of Directors and Chief Investment Officer, respectively. The independent and disinterested members of the board of directors of SUI Group reviewed and unanimously approved SUI Group's investments in Recursive and Nof1.